286 related articles for article (PubMed ID: 25620093)
1. Imidazoles and benzimidazoles as tubulin-modulators for anti-cancer therapy.
Torres FC; García-Rubiño ME; Lozano-López C; Kawano DF; Eifler-Lima VL; von Poser GL; Campos JM
Curr Med Chem; 2015; 22(11):1312-23. PubMed ID: 25620093
[TBL] [Abstract][Full Text] [Related]
2. A new class of cytotoxic agents targets tubulin and disrupts microtubule dynamics.
Al-Hamashi AA; Koranne R; Dlamini S; Alqahtani A; Karaj E; Rashid MS; Knoff JR; Dunworth M; Pflum MKH; Casero RA; Perera L; Taylor WR; Tillekeratne LMV
Bioorg Chem; 2021 Nov; 116():105297. PubMed ID: 34509798
[TBL] [Abstract][Full Text] [Related]
3. Microtubule Targeting Agents as Cancer Chemotherapeutics: An Overview of Molecular Hybrids as Stabilizing and Destabilizing Agents.
Tangutur AD; Kumar D; Krishna KV; Kantevari S
Curr Top Med Chem; 2017; 17(22):2523-2537. PubMed ID: 28056738
[TBL] [Abstract][Full Text] [Related]
4. The novel microtubule-destabilizing drug BAL27862 binds to the colchicine site of tubulin with distinct effects on microtubule organization.
Prota AE; Danel F; Bachmann F; Bargsten K; Buey RM; Pohlmann J; Reinelt S; Lane H; Steinmetz MO
J Mol Biol; 2014 Apr; 426(8):1848-60. PubMed ID: 24530796
[TBL] [Abstract][Full Text] [Related]
5. New benzimidazole-2-urea derivates as tubulin inhibitors.
Wang W; Kong D; Cheng H; Tan L; Zhang Z; Zhuang X; Long H; Zhou Y; Xu Y; Yang X; Ding K
Bioorg Med Chem Lett; 2014 Sep; 24(17):4250-3. PubMed ID: 25091926
[TBL] [Abstract][Full Text] [Related]
6. [Progress in the study of tubulin inhibitors].
Shang H; Pan L; Yang S; Chen H; Cheng MS
Yao Xue Xue Bao; 2010 Sep; 45(9):1078-88. PubMed ID: 21351562
[TBL] [Abstract][Full Text] [Related]
7. Discovery of novel 2-phenyl-imidazo[1,2-a]pyridine analogues targeting tubulin polymerization as antiproliferative agents.
An W; Wang W; Yu T; Zhang Y; Miao Z; Meng T; Shen J
Eur J Med Chem; 2016 Apr; 112():367-372. PubMed ID: 26927488
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, antiproliferative activity and molecular docking of thiocolchicine urethanes.
Majcher U; Urbaniak A; Maj E; Moshari M; Delgado M; Wietrzyk J; Bartl F; Chambers TC; Tuszynski JA; Huczyński A
Bioorg Chem; 2018 Dec; 81():553-566. PubMed ID: 30248507
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of imidazo[2,1-b]thiazole-benzimidazole conjugates as microtubule-targeting agents.
Baig MF; Nayak VL; Budaganaboyina P; Mullagiri K; Sunkari S; Gour J; Kamal A
Bioorg Chem; 2018 Apr; 77():515-526. PubMed ID: 29459129
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of new 2-chloro-4-aminopyrimidine and 2,6-dimethyl-4-aminopyrimidine derivatives as tubulin polymerization inhibitors.
Xu S; An B; Li Y; Luo X; Li X; Jia X
Bioorg Med Chem Lett; 2018 Jun; 28(10):1769-1775. PubMed ID: 29673981
[TBL] [Abstract][Full Text] [Related]
11. Quinolin-6-Yloxyacetamides Are Microtubule Destabilizing Agents That Bind to the Colchicine Site of Tubulin.
Sharma A; Sáez-Calvo G; Olieric N; de Asís Balaguer F; Barasoain I; Lamberth C; Díaz JF; Steinmetz MO
Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28640209
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of benzimidazole carbamates bearing indole moieties for antiproliferative and antitubulin activities.
Guan Q; Han C; Zuo D; Zhai M; Li Z; Zhang Q; Zhai Y; Jiang X; Bao K; Wu Y; Zhang W
Eur J Med Chem; 2014 Nov; 87():306-15. PubMed ID: 25262051
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in research of colchicine binding site inhibitors and their interaction modes with tubulin.
Sun K; Sun Z; Zhao F; Shan G; Meng Q
Future Med Chem; 2021 May; 13(9):839-858. PubMed ID: 33821673
[TBL] [Abstract][Full Text] [Related]
14. Discovery of novel 2-aryl-4-benzoyl-imidazole (ABI-III) analogues targeting tubulin polymerization as antiproliferative agents.
Chen J; Ahn S; Wang J; Lu Y; Dalton JT; Miller DD; Li W
J Med Chem; 2012 Aug; 55(16):7285-9. PubMed ID: 22783954
[TBL] [Abstract][Full Text] [Related]
15. Development of a novel class of tubulin inhibitor from desmosdumotin B with a hydroxylated bicyclic B-ring.
Nakagawa-Goto K; Oda A; Hamel E; Ohkoshi E; Lee KH; Goto M
J Med Chem; 2015 Mar; 58(5):2378-89. PubMed ID: 25695315
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and biological evaluation of combretabenzodiazepines: a novel class of anti-tubulin agents.
Galli U; Travelli C; Aprile S; Arrigoni E; Torretta S; Grosa G; Massarotti A; Sorba G; Canonico PL; Genazzani AA; Tron GC
J Med Chem; 2015 Feb; 58(3):1345-57. PubMed ID: 25584687
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation as microtubule-active agents of several tetrahydrofuran and spiroacetal derivatives.
Carda M; Murga J; Paños J; Angulo-Pachón CA; García-Pla J; Díaz-Oltra S; Marco JA; Trigili C; Redondo-Horcajo M; Díaz JF; Barasoain I
Curr Med Chem; 2013; 20(9):1173-82. PubMed ID: 23317099
[TBL] [Abstract][Full Text] [Related]
18. 4(1H)-quinolone derivatives overcome acquired resistance to anti-microtubule agents by targeting the colchicine site of β-tubulin.
Lin MS; Hong TM; Chou TH; Yang SC; Chung WC; Weng CW; Tsai ML; Cheng TR; Chen JJW; Lee TC; Wong CH; Chein RJ; Yang PC
Eur J Med Chem; 2019 Nov; 181():111584. PubMed ID: 31419740
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antiproliferative activity of novel 2-aryl-4-benzoyl-imidazole derivatives targeting tubulin polymerization.
Chen J; Li CM; Wang J; Ahn S; Wang Z; Lu Y; Dalton JT; Miller DD; Li W
Bioorg Med Chem; 2011 Aug; 19(16):4782-95. PubMed ID: 21775150
[TBL] [Abstract][Full Text] [Related]
20. Tubulin inhibitors: a patent review.
Liu YM; Chen HL; Lee HY; Liou JP
Expert Opin Ther Pat; 2014 Jan; 24(1):69-88. PubMed ID: 24313741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
